Latest financial market updates and expert analysis
Analysis The company that spent years in American courtrooms as the defendant is now turning the tables. Bayer has filed patent claims against Pfizer and Moderna over mRNA optimization technologies originally...
The whipsaw in Marvell Technology’s share price this week tells two stories at once. On Friday, the stock jumped 5.46...
The tungsten market’s most-watched Western producer is about to become a one-stop shop for investors. Almonty Industries has ended trading...
BioNTech enters one of its most consequential weeks in recent memory, juggling a freshly approved COVID-19 vaccine, a deepening patent...
The spectacle in Beijing was impressive enough — a new range-extender SUV family, aggressive pricing that undercuts Tesla, and a...
The numbers coming out of Hochtief this week have been nothing short of spectacular. A record order book approaching €85bn,...
The financing is done. The drill bit is about to turn. Now comes the part that actually decides whether Green...
For half a century, the semiconductor memory business has operated on a simple, brutal rhythm: boom, oversupply, crash, repeat. Micron...
The most closely watched technology stock on Wall Street has become a study in contradictions. Palantir closed Thursday at €106.10,...
There aren’t many companies that can land the biggest government contract in their history, watch their order book swell past...
The panic that gripped ASML’s share price lasted barely a week. By Thursday’s close, Europe’s most valuable technology company had...
